Parabilis Medicines, Inc. (PBLS) Stock Overview
Explore Parabilis Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Parabilis Medicines, Inc. (PBLS)
Key Financials
Key Financials
Market Cap
3B
P/E Ratio
-0.66
EPS (TTM)
$-9.51
ROE
-0.15%
PBLS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Parabilis Medicines, Inc. (NASDAQ: PBLS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Parabilis Medicines, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PBLS on the NASDAQ shows an RSI of 35.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $70.87 for the NASDAQ listing.
Key metrics behind Parabilis Medicines, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.66 and a market capitalization of 3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PBLS on the NASDAQ.